Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Vasopressor Choice and Timing in Vasodilatory Shock.

Literature DB >> 35337346

Vasopressor Choice and Timing in Vasodilatory Shock.

Patrick M Wieruszewski¹, Ashish K Khanna^2,3.

Abstract

This article is one of ten reviews selected from the Annual Update in Intensive Care and Emergency Medicine 2022. Other selected articles can be found online at https://www.biomedcentral.com/collections/annualupdate2022 . Further information about the Annual Update in Intensive Care and Emergency Medicine is available from https://link.springer.com/bookseries/8901 .

Entities: Chemical

Mesh：

Substances：
Vasoconstrictor Agents

Year: 2022 PMID： 35337346 PMCID： PMC8957156 DOI： 10.1186/s13054-022-03911-7

Source DB: PubMed Journal: Crit Care ISSN： 1364-8535 Impact factor: 9.097

50 in total

1. Outcome of patients receiving high dose vasopressor therapy: a retrospective cohort study.

Authors: C R Jenkins; C D Gomersall; P Leung; G M Joynt
Journal: Anaesth Intensive Care Date: 2009-03 Impact factor: 1.669

2. Tissue Perfusion and Prognosis in the Critically Ill-Is Renin the New Lactate?

Authors: Ashish K Khanna
Journal: Crit Care Med Date: 2019-02 Impact factor: 7.598

3. The Surviving Sepsis Campaign Bundle: 2018 update.

Authors: Mitchell M Levy; Laura E Evans; Andrew Rhodes
Journal: Intensive Care Med Date: 2018-04-19 Impact factor: 17.440

4. Less is more: catecholamine-sparing strategies in septic shock.

Authors: Balasubramanian Venkatesh; Ashish K Khanna; Jeremy Cohen
Journal: Intensive Care Med Date: 2019-09-13 Impact factor: 17.440

5. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021.

Authors: Laura Evans; Andrew Rhodes; Waleed Alhazzani; Massimo Antonelli; Craig M Coopersmith; Craig French; Flávia R Machado; Lauralyn Mcintyre; Marlies Ostermann; Hallie C Prescott; Christa Schorr; Steven Simpson; W Joost Wiersinga; Fayez Alshamsi; Derek C Angus; Yaseen Arabi; Luciano Azevedo; Richard Beale; Gregory Beilman; Emilie Belley-Cote; Lisa Burry; Maurizio Cecconi; John Centofanti; Angel Coz Yataco; Jan De Waele; R Phillip Dellinger; Kent Doi; Bin Du; Elisa Estenssoro; Ricard Ferrer; Charles Gomersall; Carol Hodgson; Morten Hylander Møller; Theodore Iwashyna; Shevin Jacob; Ruth Kleinpell; Michael Klompas; Younsuck Koh; Anand Kumar; Arthur Kwizera; Suzana Lobo; Henry Masur; Steven McGloughlin; Sangeeta Mehta; Yatin Mehta; Mervyn Mer; Mark Nunnally; Simon Oczkowski; Tiffany Osborn; Elizabeth Papathanassoglou; Anders Perner; Michael Puskarich; Jason Roberts; William Schweickert; Maureen Seckel; Jonathan Sevransky; Charles L Sprung; Tobias Welte; Janice Zimmerman; Mitchell Levy
Journal: Intensive Care Med Date: 2021-10-02 Impact factor: 17.440

6. Association between blood lactate levels, Sequential Organ Failure Assessment subscores, and 28-day mortality during early and late intensive care unit stay: a retrospective observational study.

Authors: Tim C Jansen; Jasper van Bommel; Roger Woodward; Paul G H Mulder; Jan Bakker
Journal: Crit Care Med Date: 2009-08 Impact factor: 7.598

7. Sensitivity to angiotensin II dose in patients with vasodilatory shock: a prespecified analysis of the ATHOS-3 trial.

Authors: Kealy R Ham; David W Boldt; Michael T McCurdy; Laurence W Busse; Raphael Favory; Michelle N Gong; Ashish K Khanna; Stefan N Chock; Feng Zeng; Lakhmir S Chawla; George F Tidmarsh; Marlies Ostermann
Journal: Ann Intensive Care Date: 2019-06-03 Impact factor: 6.925

8. Renin Kinetics Are Superior to Lactate Kinetics for Predicting In-Hospital Mortality in Hypotensive Critically Ill Patients.

Authors: Maniraj Jeyaraju; Michael T McCurdy; Andrea R Levine; Prasad Devarajan; Michael A Mazzeffi; Kristin E Mullins; Michaella Reif; David N Yim; Christopher Parrino; Allison S Lankford; Jonathan H Chow
Journal: Crit Care Med Date: 2022-01-01 Impact factor: 7.598

9. Current use of vasopressors in septic shock.

Authors: Thomas W L Scheeren; Jan Bakker; Daniel De Backer; Djillali Annane; Pierre Asfar; E Christiaan Boerma; Maurizio Cecconi; Arnaldo Dubin; Martin W Dünser; Jacques Duranteau; Anthony C Gordon; Olfa Hamzaoui; Glenn Hernández; Marc Leone; Bruno Levy; Claude Martin; Alexandre Mebazaa; Xavier Monnet; Andrea Morelli; Didier Payen; Rupert Pearse; Michael R Pinsky; Peter Radermacher; Daniel Reuter; Bernd Saugel; Yasser Sakr; Mervyn Singer; Pierre Squara; Antoine Vieillard-Baron; Philippe Vignon; Simon T Vistisen; Iwan C C van der Horst; Jean-Louis Vincent; Jean-Louis Teboul
Journal: Ann Intensive Care Date: 2019-01-30 Impact factor: 6.925

5. Low-dose norepinephrine in combination with hypotensive resuscitation may prolong the golden window for uncontrolled hemorrhagic shock in rats.

Authors: Yuanqun Zhou; Qinghui Li; Xinming Xiang; Yue Wu; Yu Zhu; Xiaoyong Peng; Liangming Liu; Tao Li
Journal: Front Physiol Date: 2022-09-19 Impact factor: 4.755

5 in total

Vasopressor Choice and Timing in Vasodilatory Shock.

1. Outcome of patients receiving high dose vasopressor therapy: a retrospective cohort study.

2. Tissue Perfusion and Prognosis in the Critically Ill-Is Renin the New Lactate?

3. The Surviving Sepsis Campaign Bundle: 2018 update.

4. Less is more: catecholamine-sparing strategies in septic shock.

5. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021.

6. Association between blood lactate levels, Sequential Organ Failure Assessment subscores, and 28-day mortality during early and late intensive care unit stay: a retrospective observational study.

7. Sensitivity to angiotensin II dose in patients with vasodilatory shock: a prespecified analysis of the ATHOS-3 trial.

8. Renin Kinetics Are Superior to Lactate Kinetics for Predicting In-Hospital Mortality in Hypotensive Critically Ill Patients.

9. Current use of vasopressors in septic shock.

10. Time to vasopressor initiation and organ failure progression in early septic shock.

1. When to start vasopressin in septic shock: the strategy we propose.

2. Comment on: Treatment strategies for clozapine-induced hypotension: A systematic review.

3. Future Perspectives in the Diagnosis and Treatment of Sepsis and Septic Shock.

4. Efficacy and safety of methylene blue in patients with vasodilatory shock: A systematic review and meta-analysis.

5. Low-dose norepinephrine in combination with hypotensive resuscitation may prolong the golden window for uncontrolled hemorrhagic shock in rats.